Videos

An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.

Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.

Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.

A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer resources for women of color with breast cancer that can help with emotional support throughout their journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to share ways patients can delegate tasks in order to take care of themselves during their cancer journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer background on what exactly resilience during breast cancer is.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to highlight the importance of having difficult conversations with one’s family about a breast cancer diagnosis and its treatment.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss mental resilience during one’s breast cancer journey.

A comprehensive review of treatment options for patients with metastatic hormone-sensitive prostate cancer.

Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.

A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.

Expert perspectives on how clinical trials and real-world evidence contribute to treatment decisions in prostate cancer.

A comprehensive overview of systemic therapies available for the treatment of patients with advanced renal cell carcinoma.

Experts in the field of kidney cancer discuss the risk stratification process for renal cell carcinoma and its effect on prognosis.

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant.

The notion of ‘time toxicity’ causes patients with stage 4 melanoma to have less available time in their everyday lives because of appointments and treatments.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about prognostic and predictive outcomes in breast cancer, and the options available as a result.

As part of its Speaking Out video series, CURE spoke with Juanita Miller, an ANGEL Advocate from the Tigerlily Foundation, about fear of recurrence after breast cancer.

A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer.

An experienced public health and cancer researcher offers advice to patients newly diagnosed with prostate cancer and discusses barriers to access to care.

Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.

Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.

Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.

Clinical insights on the typical presentation of kidney cancer and the diagnostic process.